What's New
Last Posted: Mar 08, 2020
- Deep learning radiomics can predict axillary lymph node status in early-stage breast cancer
Y Zheng et al, Nat comms, March 2020 - Whole tumor genomes across cancers.
et al. Nature genetics 2020 Mar (3) 241 - Evaluating the Use of Circulating MicroRNA Profiles for Lung Cancer Detection in Symptomatic Patients
T Fehlmann et al, JAMA Oncology, March 5, 2020 - Risk stratification of prostate cancer through quantitative assessment of PTEN loss (qPTEN)
JNCI, March 2020 - The Challenges of Optimizing Biomarkers To Guide Clinical Decision Making
SM Hewitt JNCI, March 4, 2020 - Evaluation of Combined Artificial Intelligence and Radiologist Assessment to Interpret Screening Mammograms
T Schaffer et al, JAMA Network Open, March 2020 - A Turing test for artificial intelligence in cancer
Nature Cancer, February 2020 - Artificial intelligence and cancer
Nature Cancer, February 2020 - Tumor Mutational Burden From Tumor-Only Sequencing Compared With Germline Subtraction From Paired Tumor and Normal Specimens
K Parikh et al, JAMA Network Open, February 28, 2020 - Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field.
Yanes Tatiane et al. Breast cancer research : BCR 2020 Feb 22(1) 21 - Comparing an artificial neural network to logistic regression for predicting ED visit risk among patients with cancer: a population-based cohort study.
Sutradhar Rinku et al. Journal of pain and symptom management 2020 Feb - A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade.
Hermanns Thomas et al. Urologic oncology 2020 Feb - Automatic Recognition of Laryngoscopic Images Using a Deep-Learning Technique.
Ren Jianjun et al. The Laryngoscope 2020 Feb - Current applications and challenges of circulating tumor DNA (ctDNA) in squamous cell carcinoma of the head and neck (SCCHN).
Galot Rachel et al. Cancer treatment reviews 2020 Feb 85101992 - Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma.
Zhang Yingying et al. Medical science monitor : international medical journal of experimental and clinical research 2020 Feb 26e919644
No hay comentarios:
Publicar un comentario